Most teams that need this are short a person, not short a tool.
Buying the platform still leaves someone to fill in the inventory, chase the documents, and assemble the pack before the exam. In a two-person risk function that someone does not exist, and the CRO is the one who answers for the gap. These four engagements do that work with you, on your data, in your Coriqo instance. Each has a fixed scope and a fixed fee, and we state our boundary before you ask.
We assemble the evidence and lock it into the record. We never sign the validation opinion. SR 26-2 expects validation to be independent of the model owner. A vendor that sold you the evidence platform is in no position to also write the conclusion kept inside it. Our work stops at readiness: your second line, or an independent validator you choose, makes the call. If you would rather we did both, we will refer you to a firm that can do the second half.
Software nobody has time to fill in ends up unused, and we would rather say so.
Two findings shaped this decision. Both argue against selling a licence and walking away.
Across roughly 300 deployments, the projects that worked were the ones somebody embedded in; the ones that failed were generic tools handed over at the contract signing.
MIT NANDA, The GenAI Divide, August 2025The reasons given are cost, unclear value, and inadequate risk controls. The third one is the part we can actually fix, and it is easier to fix with someone in the room.
Gartner forecastYour agents are already acting. Someone should be able to say what they actually do.
When a board or an examiner asks that question, a vendor slide deck is not an answer. This engagement produces a real one. We run a defined set of tests against one of your agents, at a fixed version, in your own environment. The results are locked into the record so a reviewer outside your company can check them.
A repeat finding costs more than the first.
If your regulator has already said a control failed, it will come back to ask whether the fix worked and whether it still does. We take one order and leave you with a record of it that your examiner can check themselves. Fixed fee, scoped on a call.
Each one ends with something your examiner can check without taking our word for it.
Every engagement runs inside your own Coriqo instance and requires an active subscription. We scope on a call and quote a fixed fee; there is no hourly rate and no open-ended retainer. We price per deliverable, and each one can be counted in your own record, so afterwards you can point at what you paid for.
Four things we don't sell, and the reason for each.
A short list is more useful to you than a long one, and it tells you what we are before the third call.
Independence. We prepare the evidence; somebody else concludes on it. This is the boundary at the top of the page and it does not move per engagement.
Staff augmentation turns into a headcount line that never ends and a product that stops improving. Every engagement here has a defined end.
We are not a consulting firm and are not trying to become one. Services stay a minority of revenue on purpose, so the platform keeps getting built.
Nobody can sell you a passed exam. We can get the evidence into a state where the questions have answers, which is a different claim and an honest one.
Asked by risk officers, procurement, and the firm that already does your validation.
Tell us what is coming and when, and we will tell you which one you need.
Sometimes the answer is none of them. If your inventory is already clean, S1 is a waste of your money and we will say so on the call. Email us directly; there is no sales queue to sit in.
No forms. Email us directly and we'll respond within one business day.
Send us an emailor copy: abdul@coriqo.io